CanSino Claims Lead In COVID-19 Vaccine Race And Takes Swipe At Moderna’s Ethics
Will Be First To Publish Phase II Results
Vaccines veteran calls Moderna ‘shabby’ for lack of transparency and shares sell-off, and flags CanSino’s own forthcoming Phase II results.
